Avelos Therapeutics Inc. announced that it has raised $8 million in a round of funding on August 22, 2022. The Transaction included the participation from SV Investment Corporation, UTC Investment Co., Ltd., Quad Investment Management Corp., Mirae Asset Venture Investment Co., Ltd., Mirae Asset Capital Co,Ltd., Investment Arm and Timepolio Asset Management.